Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (KCT0012807) titled 'A clinical study to evaluate the efficacy of HT074 in adults with indigestion symptoms' on Oct. 21.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT
Primary Sponsor: Neumed
Condition:
Diseases of the digestive system
Intervention:
Dietary Supplement : Participants in all intervention groups take their assigned product orally for 8 weeks, with one tablet in the morning and one tablet in the evening (two tablets per day). The interventions for each group are described below...